首页> 外文OA文献 >Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME)

【2h】

Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME)

机译：Sunitinib后细胞射孔肾切除术的手术安全：MultiCeltre，随机对照试验的直接与延期肾切除术（SURTIME）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Roderick Emile De Bruijn; Peter Mulders; Michael A. Jewett; John Wagstaff; Johan V. Van Thienen; Christian U. Blank; Roland Van Velthoven; Lori Wood; Harm E. van Melick; Maureen J. Aarts; Jean B. Lattouf; Thomas Powles; Igle J. De Jong; Sylvie Rottey; Betrand Tombal; Sandrine Marreaud; Sandra Collette; Laurence Collette; John B. Haanen; Axel Bex;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME) [J] . De Bruijn Roderick Emile, Mulders Peter, Jewett Michael A., European urology . 2019,第4期

机译：Sunitinib以下细胞射孔肾切除术的手术安全：Multicentre，随机对照试验的即时与延期肾切除术（Surtime）
2. IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial [J] . Rini Brian I., Stenzl Arnulf, Zdrojowy Romauld, The lancet oncology . 2016,第11期

机译：IMA901，一种多肽类癌症疫苗，加舒尼替尼与单独舒尼替尼比较，作为晚期或转移性肾细胞癌（IMPRINT）的一线治疗：一项多中心，开放标签，随机，对照，3期试验
3. An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial. [J] . Wood C, Srivastava P, Bukowski R, The Lancet . 2008,第9633期

机译：肾细胞癌肾切除术后高复发风险患者的辅助自体治疗疫苗（HSPPC-96; vitespen）与单独观察：一项多中心，开放标签，随机III期试验。
4. Modeling the Surgical Exposure of Anatomy in Robot-Assisted Laparoscopic Partial Nephrectomy [C] . Michael A. Kokko, John D. Seigne, Douglas W. Van Citters, Conference on Medical Imaging: Image-Guided Procedures, Robotic Interventions, and Modeling . 2020

机译：机器人辅助腹腔镜部分肾切除术中解剖学手术暴露的建模
5. The early external cephalic version (ECV) trial: A randomised controlled trial of ECV beginning at between 34--36 weeks compared to 37--38 weeks gestation. [D] . Hutton, Eileen Katherine McNally. 2003

机译：早期体外头颅试验（ECV）：一项ECV随机对照试验始于妊娠34--36周，而妊娠37--38周。
6. Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial [O] . A Bex, P Mulders, M Jewett, 2020

机译：社论评论：接受舒尼替尼治疗的同步转移性肾细胞癌患者立即进行和延迟行细胞还原肾切除术的比较：SURTIME随机临床试验
7. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II) [O] . W. J. Koemans, R. T. van der Kaaij, H. Boot, 2019

机译：细胞功能性手术和高温腹膜内化疗与胃癌患者腹膜传播患者的姑息性全身化疗，多期式随机对照试验的研究方案（Periscope II）

Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME)

著录项

相似文献

相关主题

期刊订阅